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data suggested a better comfort for the patient for linac-
based therapy, due to the shorter treatment time and the 
non-invasive immobilization system. Dosimetric data for the 
patients treated according to this protocol suggest a 
substantial balance between Gamma Knife and Linac EDGE 
treatments 
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Purpose or Objective: By pooling data of five large 
prospective studies/Institutional series, a large data base of 
pT2-pT3, pN0 patients treated either in the adjuvant or in 
the salvage setting with conventionally fractionated (1.8-2.0 
Gy/fr) 3DCRT post-prostatectomy radiotherapy (RT) was 
available. The aim of the study was to fit individual data of 
biochemical-recurrence-free survival (bRFS) with a 
comprehensive Poisson-based TCP model. 
 
Material and Methods: Considering pre-RT PSA as a surrogate 
of the number of clonogens, 5-year bRFS was expressed as a 
function of the dose depending on radiosensitivity (α_eff), 
number of clonogens for pre-RT PSA=1ng/mL (C) and the 
fraction of patients that relapses due to clonogens outside 
the treated volume, assumed to linearly depend on pre-RT 
PSA (K=1-BxPSA), according to:  
bRFS = (1-B x PSA) x [1 - exp (-α_eff D)]^CxPSA.  
In addition, the impact of Gleason score (GS) was included by 
performing separate fits for different sub-groups, depending 
on GS (<7,=7,>7). In total, complete data regarding bRFS, 
dose, pre-RT PSA (between 0.01 and 2.0 ng/ml) and GS of 
894 hormono-naive patients treated with adjuvant (n=331) or 
salvage (n=563) intent with a minimum follow-up of 3 years 
were available. Patients with GS<7, =7 and >7 were 392, 383, 
and 119 respectively. Best-fit procedures were performed 
with the sequential quadratic programming, using the sum of 
the squared residuals error as loss function (SPSS v.17, SPSS 
Inc., Chicago, IL). The 95% CI of the parameter’s best-fit 
values were calculated by bootstrap. The performance of the 
resulting model was assessed by calibration plot. 
 
Results: The median follow-up was 72 months; median pre-
RT PSA and dose were 0.25 ng/mL (inter-quartile range: 0.1-
0.5) and 66.6Gy (range:59.4-77.4Gy) respectively. The fit 
converged in all situations: depending on GS, best-fit values 
were in the range 0.20-0.22 Gy-1 and 10^6 for α_eff and C 
respectively; the maximum obtainable bRFS was reduced by 
1.7, 4.9 and 5.6% for each 0.1ng/ml PSA increment for GS<7, 
=7 and >7 respectively. The calibration plot showed an 
excellent agreement between predicted and expected values 
(R2=0.96) and the AUC was 0.69 (95% CI: 0.66-0.73). The 
bRFS curves as estimated by the model vs prescribed dose for 
different pre-RT PSA (between 0.1 and 1.0 ng/ml) and for the 
three GS groups are plotted in the figure. 
 
 
Conclusion: Long-term bRFS data of a large multi-centric 
data base of post-prostatectomy patients could be fitted by a 
radiobiologically consistent TCP model, showing a dose-effect 
critically depending on pre-RT PSA and GS. The model 
suggests that most relapses occur in patients with clonogens 
outside the treated volume, indirectly supporting lymph-
nodal irradiation and/or systemic therapy for specific risk 
groups, depending on pre-RT PSA and GS. Early RT is 
preferred over delayed RT as the detrimental effect due to a 
PSA increase can never be compensated by increasing the 
dose, more dramatically evident for patients with GS ≥7. 
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Purpose or Objective: Traditional normal tissue complication 
probability (NTCP) models rely on dose-volume histogram 
(DVH) analysis, which disregards any spatial dose distribution 
information and possible inhomogeneity in regional organ 
radio-sensitivity. We propose a voxel-based (VB) approach to 
correlate local lung dose and radiation-induced lung damage 
(RILD). 
 
Material and Methods: An inter-institutional database of 115 
Hodgkin lymphoma survivors treated with sequential chemo-
radiotherapy (with 18 RILD cases after treatment) were 
included in the study. Sixteen patients were excluded due to 
an inadequate CT coverage of the lungs. 
Each patient dataset was first normalized to a common 
template. Pre-registration steps were based on a binary mask 
extrapolated from the organ at risk segmentations of the 
treatment plan. For each patient, the mask, computed as the 
union and dilation (spherical structuring element of radius 30 
mm) of heart and lung structures, was used to crop the field-
of-view, allowing a coarse alignment of the structures of 
interest. CT images were masked accordingly in order to hide 
some anatomical inter-individual differences, and allowed 
the registration algorithm to work more efficiently on tissue 
contrast inside the chest. The median lung-volume patient 
was chosen as reference image in the non-rigid registration 
and a log-diffeomorphic approach [1] was used. The obtained 
deformation fields were then used to map the dose of each 
patient to the common coordinate system of the reference 
patient. 
A voxel-wise two-sample t-test was then performed on the 
normalized dose maps and statistically significance of the 
differences between groups was displayed as p-value map. 
 
Results: The robustness of co-registration process was 
assessed both by visual inspection (Fig. 1a-b) and by Dice 
scores for the lungs (Fig. 1c). On the whole population, the 
median Dice value was 0.94 (range: [0.87; 0.95]). As shown in 
